Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
96 hedge funds and large institutions have $676M invested in Myovant Sciences Ltd. in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 13 closing their positions.
167% more capital invested
Capital invested by funds: $253M → $676M (+$423M)
162% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 13
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
28% more funds holding
Funds holding: 75 → 96 (+21)
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
28% less call options, than puts
Call options by funds: $5.97M | Put options by funds: $8.28M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.3M |
| 2 |
VA
VR Adviser
New York
|
+$11.5M |
| 3 |
EP
Eversept Partners
New York
|
+$10.3M |
| 4 |
Millennium Management
New York
|
+$7.66M |
| 5 |
Renaissance Technologies
New York
|
+$7.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$40.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$14.2M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$9.28M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$7.08M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$6.04M |
MYOV Hedge Fund Activity: Q2 2020 in Review
96 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2020, worth a combined $676M — up 167% from $253M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new MYOV positions and 13 closed out — a net gain of 21 holders — while 30 added to existing stakes and 26 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $30.3M. The largest seller was Victory Capital Management, cutting an estimated $40.5M.
- 96 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2020, up from 75 in Q1 2020.
- Funds reported $676M of Myovant Sciences Ltd. stock for Q2 2020, up 167% quarter-over-quarter.
- 34 funds opened new Myovant Sciences Ltd. positions in Q2 2020 and 13 closed out, a net change of +21 holders.
- The largest Myovant Sciences Ltd. buyer in Q2 2020 was Fidelity Investments, an estimated $30.3M added.
- The largest Myovant Sciences Ltd. seller in Q2 2020 was Victory Capital Management, an estimated $40.5M sold.
Based on aggregated 13F filings for Q2 2020.